$XBP
XBP Europe Holdings Inc Stock $xbp

$xbp Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000121390022048087 Filed on August 15, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$513.0K	$413.8K	$991.2K
YoY Change	23.91%	300.18%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$513.0K	$413.8K	$991.2K
YoY Change	23.91%	300.18%
Operating Profit	-$513.0K	-$413.8K
YoY Change	23.91%
Interest Expense	$1.090M	$53.77K	$520.00
YoY Change	-553.75%	-102.89%
% of Operating Profit
Other Income/Expense, Net	$429.1K	$3.772M	$1.723M
YoY Change	-60.7%	2635.23%
Pretax Income	$1.006M	$3.412M	$732.7K
YoY Change	129.76%	-287.18%
Income Tax	$40.00K
% Of Pretax Income	3.98%
Net Earnings	$965.4K	$3.412M	$732.7K
YoY Change	120.56%	-287.17%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$33.39K	$110.3K	$23.01K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.475M	$25.00K	$25.00K
YoY Change	2132.07%	0.0%
Cash & Equivalents	$1.475M	$25.00K	$25.00K
Short-Term Investments
Other Short-Term Assets	$284.3K	$44.63K	$195.5K
YoY Change	-61.1%	-95.32%
Inventory
Prepaid Expenses	$284.3K		$195.5K
Receivables			$35.11M
Other Receivables
Total Short-Term Assets	$1.759M	$69.63K	$220.5K
YoY Change	120.73%	-92.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill			$23.95M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$225.7M	$225.6M	$250.0M
YoY Change	-9.71%	-9.75%
Other Assets		$570.8K	$570.8K
YoY Change
Total Long-Term Assets	$225.7M	$226.2M	$250.6M
YoY Change	-9.91%	-9.52%
TOTAL ASSETS
Total Short-Term Assets	$1.759M	$69.63K	$220.5K
Total Long-Term Assets	$225.7M	$226.2M	$250.6M
Total Assets	$227.5M	$226.3M	$250.8M
YoY Change	-9.5%	-9.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$173.6K	$815.5K	$1.349M
YoY Change	251.09%	3744.88%
Deferred Revenue			$5.760M
YoY Change
Short-Term Debt	$6.902M	$5.452M	$734.4K
YoY Change	1017.65%	972.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.560M	$6.889M	$2.854M
YoY Change	536.72%	1141.14%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.980M	$4.066M	$7.307M
YoY Change	-67.58%	-59.49%
Total Long-Term Liabilities	$2.980M	$4.066M	$7.307M
YoY Change	-67.58%	-59.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.560M	$6.889M	$2.854M
Total Long-Term Liabilities	$2.980M	$4.066M	$7.307M
Total Liabilities	$11.54M	$10.95M	$10.16M
YoY Change	9.54%	3.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.350M		-$9.499M
YoY Change
Common Stock	$54.00		$54.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.678M	-$10.31M	-$9.352M
YoY Change
Total Liabilities & Shareholders Equity	$227.5M	$226.3M	$250.8M
YoY Change	-9.5%	-9.85%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	$965.4K	$3.412M	$732.7K
YoY Change	120.56%	-287.17%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$0.00		$0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$24.40M	$0.00
YoY Change		-109.76%
Cash From Investing Activities	$0.00	$24.40M	$0.00
YoY Change		-109.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.450M	-24.40M	0.000
YoY Change	3429.9%	-109.76%
NET CHANGE
Cash From Operating Activities	0.000		0.000
Cash From Investing Activities	0.000	24.40M	0.000
Cash From Financing Activities	1.450M	-24.40M	0.000
Net Change In Cash	1.450M	$0.00	0.000
YoY Change	3429.9%
FREE CASH FLOW
Cash From Operating Activities	$0.00		$0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	CF ACQUISITION CORP. VIII
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-40206
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2002883
	dei	Entity Address Address Line1 EntityAddressAddressLine1	110 East 59th Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	938-5000
	dei	Security12b Title Security12bTitle	Class A common stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	CFFE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	us-gaap	Cash Cash	1474727	usd
CY2021Q4	us-gaap	Cash Cash	25000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	284298	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	195463	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1759025	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	220463	usd
CY2022Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	1571215	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	250017673	usd
CY2022Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	224485500	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	224156250	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	570844	usd
CY2022Q2	us-gaap	Assets Assets	227486490	usd
CY2021Q4	us-gaap	Assets Assets	250808980	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	173649	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1349132	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1449727	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	570844	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6901927	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	734425	usd
CY2022Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	35033	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	200000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8560336	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2854401	usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1677978	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5300188	usd
CY2022Q2	cffe	Forward Purchase Securities Liability ForwardPurchaseSecuritiesLiability	1301570	usd
CY2021Q4	cffe	Forward Purchase Securities Liability ForwardPurchaseSecuritiesLiability	2006525	usd
CY2022Q2	us-gaap	Liabilities Liabilities	11539884	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10161114	usd
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	225624745	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	250000000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	30000	usd
CY2021Q2	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	30000	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	60000	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	35187	usd
CY2022Q2	us-gaap	Taxes Other TaxesOther	50000	usd
CY2021Q2	us-gaap	Taxes Other TaxesOther	60050	usd
	us-gaap	Taxes Other TaxesOther	62534	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	54	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	54	usd
CY2022Q2	cffe	Common Stock Value One CommonStockValueOne	625	usd
CY2021Q4	cffe	Common Stock Value One CommonStockValueOne	625	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	146555	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9349568	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9499368	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-329250	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-9678139	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9352134	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	227486490	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	250808980	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	433001	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	323948	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	804255	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	401709	usd
	us-gaap	Taxes Other TaxesOther	80500	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-513001	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-413998	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-926789	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-517396	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	431970	usd
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther	5138	usd
	us-gaap	Interest Income Other InterestIncomeOther	438410	usd
	us-gaap	Interest Income Other InterestIncomeOther	5138	usd
	us-gaap	Other Income OtherIncome	579294	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-429072	usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1091835	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3622210	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1229751	usd
CY2022Q2	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	-657626	usd
CY2021Q2	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	245264	usd
	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	-704955	usd
	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	2102896	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1005667	usd
CY2021Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	437711	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	4418080	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1385403	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40231	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40231	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	965436	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	437711	usd
	us-gaap	Net Income Loss NetIncomeLoss	4377849	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1385403	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	965436	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	437711	usd
	us-gaap	Net Income Loss NetIncomeLoss	4377849	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1385403	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-329250	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-329250	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-329250	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-329250	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	636186	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	437711	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4048599	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1385403	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9352134	usd
CY2022Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4424015	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	49411	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3412413	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-10314325	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	965436	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-329250	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-9678139	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	23579	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5224149	usd
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	13038572	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1823114	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-9613958	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	437711	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-9176247	usd
	us-gaap	Net Income Loss NetIncomeLoss	4377849	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1385403	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	49411	usd
	cffe	General And Administrative Expenses Paid By Related Party GeneralAndAdministrativeExpensesPaidByRelatedParty	1137256	usd
	cffe	General And Administrative Expenses Paid By Related Party GeneralAndAdministrativeExpensesPaidByRelatedParty	348295	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	438410	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5138	usd
	cffe	Changes In Fair Value Of Warrant Liability ChangesInFairValueOfWarrantLiability	-3622210	usd
	cffe	Changes In Fair Value Of Warrant Liability ChangesInFairValueOfWarrantLiability	-1229751	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-704955	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	2102896	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4900000	usd
	us-gaap	Other Expenses OtherExpenses	100000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-541509	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1175483	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	48036	usd
	cffe	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	164967	usd
	cffe	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-80000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	556374	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	597439	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	4424015	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	250000000	usd
	cffe	Proceeds From Trust Account To Pay Franchise Taxes ProceedsFromTrustAccountToPayFranchiseTaxes	24113	usd
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	224056750	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	224056750	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	28799270	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	24399368	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-250000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	6167502	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	617542	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	250000000	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	28799270	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5400000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4897322	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	317873	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1079155	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22949641	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	250041065	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1449727	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	41065	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1474727	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	66065	usd
	cffe	Prepaid Expenses Paid With Payables To Related Party PrepaidExpensesPaidWithPayablesToRelatedParty	730860	usd
CY2022Q2	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	400000	usd
	cffe	Redeem Public Share Percentage RedeemPublicSharePercentage	1	pure
CY2022Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.2
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1475000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	25000	usd
CY2022Q2	cffe	Working Capital WorkingCapital	6801000	usd
CY2021Q4	cffe	Working Capital WorkingCapital	2634000	usd
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	The Company’s liquidity needs through June 30, 2022 have been satisfied through a contribution of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, a loan of approximately $79,000 from the Sponsor pursuant to a promissory note (the “Pre-IPO Note”) (see Note 4), the proceeds from the sale of the Private Placement Units not held in the Trust Account, and the Sponsor Loan (as defined below).
CY2022Q2	cffe	Maximum Sponsor Loan MaximumSponsorLoan	1750000	usd
	cffe	Working Capital Loan WorkingCapitalLoan	1000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability and FPS liability. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation maximum coverage limit of $250,000, and cash equivalents and investments in the U.S. government debt securities held in the Trust Account. For the three and six months ended June 30, 2022 and 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.009	pure
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.009	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021Q1	cffe	Issued And Outstanding Common Stock Percentage IssuedAndOutstandingCommonStockPercentage	0.20	pure
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000	usd
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On March 11, 2021, the Company effected a 1.1-for-1 stock split
CY2021Q1	cffe	Initial Shareholders Holding Percentage InitialShareholdersHoldingPercentage	0.20	pure
CY2022Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.2
	cffe	Working Capital Loans WorkingCapitalLoans	728000	usd
CY2021	cffe	Working Capital Loans WorkingCapitalLoans	0	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	1450000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	571000	usd
CY2022Q2	cffe	Available For Sale In Securities Amortized Cost AvailableForSaleInSecuritiesAmortizedCost	224485500	usd
	cffe	Available For Sale In Securities Gross Unrealized Loss AvailableForSaleInSecuritiesGrossUnrealizedLoss	329250	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	224156250	usd
	cffe	Issued And Outstanding Ordinary Shares Percentage IssuedAndOutstandingOrdinarySharesPercentage	0.20	pure
CY2021Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1.1-for-1
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	cffe	Public Warrants Term PublicWarrantsTerm	P5Y
	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	●in whole and not in part; ●at a price of $0.01 per warrant; ●at any time during the exercise period; ●upon a minimum of 30 days’ prior written notice of redemption; ●if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ●if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	10000000	usd
CY2022Q2	us-gaap	Commitments Fair Value Disclosure CommitmentsFairValueDisclosure	10000000	usd
	cffe	Business Of Combination Percentage BusinessOfCombinationPercentage	0.43	pure
CY2021	cffe	Business Of Combination Percentage BusinessOfCombinationPercentage	0.80	pure
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent		usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	cffe	Proceeds From Trust Account To Pay Franchise Taxes ProceedsFromTrustAccountToPayFranchiseTaxes		usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	cffe	Prepaid Expenses Paid With Payables To Related Party PrepaidExpensesPaidWithPayablesToRelatedParty		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	cffe	Available For Sale In Securities Gross Unrealized Gains AvailableForSaleInSecuritiesGrossUnrealizedGains		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001839530

Files In Submission

Name	View Source	Status
0001213900-22-048087-index-headers.html	Edgar Link	pending
0001213900-22-048087-index.html	Edgar Link	pending
0001213900-22-048087.txt	Edgar Link	pending
0001213900-22-048087-xbrl.zip	Edgar Link	pending
cffe-20220630.xsd	Edgar Link	pending
f10q0622ex10-1_cfacq8.htm	Edgar Link	pending
f10q0622ex31-1_cfacq8.htm	Edgar Link	pending
f10q0622ex31-2_cfacq8.htm	Edgar Link	pending
f10q0622ex32-1_cfacq8.htm	Edgar Link	pending
f10q0622ex32-2_cfacq8.htm	Edgar Link	pending
f10q0622_cfacq8.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
cffe-20220630_def.xml	Edgar Link	unprocessable
cffe-20220630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cffe-20220630_pre.xml	Edgar Link	unprocessable
f10q0622_cfacq8_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cffe-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XBP
XBP Europe Holdings Inc Stock $xbp

2022 Q2 Form 10-Q Financial Statement

#000121390022048087 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XBP XBP Europe Holdings Inc Stock $xbp

2022 Q2 Form 10-Q Financial Statement

#000121390022048087 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XBP
XBP Europe Holdings Inc Stock $xbp